PULMOCIDE
Pulmocide Ltd, a company focused on the discovery and development of a new generation of inhaled medicines for the treatment of serious viral and fungal infections of the respiratory tract.
PULMOCIDE
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Medical Medical Device
Founded:
2013-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.pulmocide.com
Total Employee:
11+
Status:
Active
Contact:
+44 207 594 1210
Email Addresses:
[email protected]
Total Funding:
153.46 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
NociTech
NociTech has developed a novel advanced pain test platform that enables a mechanism-based quantification of pain sensitivity.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation investment in Grant - Pulmocide
Jeito Capital
Jeito Capital investment in Series C - Pulmocide
Adjuvant Capital
Adjuvant Capital investment in Series C - Pulmocide
SV Health Investors
SV Health Investors investment in Series C - Pulmocide
F-Prime Capital
F-Prime Capital investment in Series C - Pulmocide
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Series C - Pulmocide
SR One
SR One investment in Series C - Pulmocide
IP Group
IP Group investment in Series C - Pulmocide
Asahi Kasei Pharma
Asahi Kasei Pharma investment in Series C - Pulmocide
Longwood Fund
Longwood Fund investment in Series C - Pulmocide
Official Site Inspections
http://www.pulmocide.com Semrush global rank: 6.18 M Semrush visits lastest month: 1.3 K
- Host name: pulmocide.tempurl.host
- IP address: 45.76.139.2
- Location: London United Kingdom
- Latitude: 51.5128
- Longitude: -0.0638
- Timezone: Europe/London
- Postal: E1
More informations about "Pulmocide"
Treating difficult respiratory diseases | About Pulmocide
Learn how Pulmocide discovers and develops innovative inhaled treatments for respiratory fungal infections and other infectious diseases.See details»
Developing targeted therapies for serious respiratory …
Pulmocide is a biotechnology company developing novel inhaled medicines for pulmonary aspergillosis and other hard-to-treat respiratory diseases.See details»
Pulmocide - Overview, News & Similar companies | ZoomInfo.com
View Pulmocide (www.pulmocide.com) location in Greater London, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Pulmocide Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Pulmocide Ltd. with its drug pipeline, therapeutic area, technology platform, 10 clinical trials, 12 news, and 31 literature, Disease Domain:Infectious ...See details»
Pulmocide Company Profile | Management and Employees List
Pulmocide Profile and History Pulmocide is a unique biopharmaceutical company with a mission to treat common acute and chronic respiratory tract infections associated with serious …See details»
Pulmocide - 2025 Company Profile - Tracxn
Apr 25, 2025 Pulmocide is a series C company based in London (United Kingdom), founded in 2013. It operates as a Developer of inhalation therapeutics for respiratory infections. …See details»
Pulmocide Company Profile - Office Locations, Competitors ... - Craft
Pulmocide has 5 employees across 2 locations and $57.54 m in total funding,. See insights on Pulmocide including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Pulmocide - Products, Competitors, Financials, Employees, …
Pulmocide is a biotechnology company that engages in developing therapies for respiratory diseases within the biopharmaceutical sector. Use the CB Insights Platform to explore …See details»
Pulmocide - Crunchbase Company Profile & Funding
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.See details»
Pulmocide Announces Expansion of Management Team
Jun 8, 2023 Together, the Pulmocide management team has a history of successful company development, including product development and approval, manufacturing, business …See details»
Pulmocide 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Pulmocide. Use the PitchBook Platform to explore the full profile.See details»
Pulmocide | LinkedIn
Pulmocide | 1,706 followers on LinkedIn. Developing best-in-class inhaled medicines for targeted treatment of life-threatening respiratory diseases. | Pulmocide is a biopharmaceutical company …See details»
Longwood Fund - Pulmocide
Pulmocide is a unique biopharmaceutical company with a mission to treat common acute and chronic respiratory tract infections associated with serious complications and devastating …See details»
Pulmocide Limited Overview | SignalHire Company Profile
Pulmocide Limited is a private company that has been in the industry for 17 years. The company currently specializes in the Research, Biotechnology, Pharmaceuticals areas.See details»
About Pulmocide
Jan 26, 2024 Pulmocide Ltd (www.pulmocide.com) is a late-stage biopharmaceutical company focused on the development of a novel inhaled azole therapy for patients at risk of developing …See details»
Pulmocide - Profiles & Contacts - Crunchbase
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.See details»
Pulmocide - Funding, Financials, Valuation & Investors
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.See details»
Pulmocide - The Org
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.See details»
Press Release | Pulmocide
Pulmocide Announces New Clinical Data Confirming Low Potential for Drug-Drug Interactions with Inhaled Opelconazole Press Release / lsc-webmaster LONDON – October 16, 2023 – …See details»
Pulmocide - News, Locations, Executives and Competitors - Usearch
Pulmocide is a unique biopharmaceutical company with a mission to treat common acute and chronic respiratory tract infections associated with serious complicati...See details»